benzonidazole has been researched along with resolvin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Barbosa, C; Carrillo, I; Castillo, C; Díaz-Araya, G; Fuentes-Retamal, S; González-Herrera, F; Guzmán-Rivera, D; Kemmerling, U; Machado, FS; Maya, JD; Quintero, H; Rabelo, RAN; Rates, M | 1 |
1 other study(ies) available for benzonidazole and resolvin d1
Article | Year |
---|---|
Aspirin-triggered resolvin D1 reduces parasitic cardiac load by decreasing inflammation in a murine model of early chronic Chagas disease.
Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Disease Models, Animal; Docosahexaenoic Acids; Female; Heart; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Nitroimidazoles; Parasite Load; Receptors, Formyl Peptide; Trypanosoma cruzi | 2021 |